Institutional Investor RTW Investments Increases Potential Stake in Orchestra BioMed to 19.7%

summarizeSummary

RTW Investments increased the maximum exercisability of its pre-funded warrants, leading to a deemed beneficial ownership of 19.7% of Orchestra BioMed, including an additional 3.6 million shares.

check_boxKey Events

• Increased Warrant Exercisability

  RTW Funds submitted notices to the Issuer increasing the Maximum Percentage under their Pre-Funded Warrants from 9.99% to 19.99%.

• Significant Deemed Ownership Increase

  This adjustment results in the Reporting Persons being deemed to beneficially own an additional 3,636,363 shares of common stock.

• Total Beneficial Ownership

  RTW Investments, LP and its affiliates now beneficially own 11,942,426 shares, representing 19.7% of the outstanding common stock.

• No Recent Transactions

  The filing explicitly states that none of the Reporting Persons have effected any transactions with respect to the Issuer's securities during the past sixty days.

auto_awesomeAnalysis

RTW Investments, a significant institutional holder, amended its Schedule 13D to reflect an increase in the maximum percentage for its pre-funded warrants from 9.99% to 19.99%. This technical adjustment allows RTW to be deemed to beneficially own an additional 3.6 million shares, bringing their total potential beneficial ownership to 19.7% of Orchestra BioMed. While not an immediate share purchase, this move indicates RTW's continued flexibility and potential to increase its stake in the company, signaling ongoing interest from a major investor.